CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- 4 Planned sale SVP, Finance & CAO sold 2,500 shares at $58.59 ($146,482)
- 4 Planned sale CHIEF OPERATING OFFICER sold 7,395 shares at an average $58.88 ($435,440)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Option exercise SVP, Finance & CAO acquired 7,716 shares (option exercise)
- 4 Shares withheld for taxes PRESIDENT AND CFO gave up 1,907 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 5,394 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Technical Ops Officer gave up 757 shares (to pay taxes)
- 4 Grant or award CHIEF OPERATING OFFICER acquired 37,147 shares (grant or award)
- 8-K Event Other events
- 424B5 Offering Prospectus
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 4 Gift CHIEF EXECUTIVE OFFICER gave 100,000 shares (gift)
- 4 Gift PRESIDENT AND CFO gave 61,850 shares (gift)
Page 6 of 39 · 770 filings